• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 MRI 的术前标志物联合窄切缘肝切除术导致更高的早期复发率。

MRI-based preoperative markers combined with narrow-margin hepatectomy result in higher early recurrence.

机构信息

Department of Radiology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China.

Department of Radiology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China.

出版信息

Eur J Radiol. 2022 Dec;157:110521. doi: 10.1016/j.ejrad.2022.110521. Epub 2022 Sep 11.

DOI:10.1016/j.ejrad.2022.110521
PMID:36274362
Abstract

PURPOSE

To investigate the applicability of MRI-based preoperative risk markers in assisting clinicians to define an appropriate surgical margin width for patients with solitary hepatocellular carcinoma.

METHODS

Patients who underwent preoperative MRI with hepatectomy were randomly divided into development (65%) and internal validation (35%) datasets between January 2015 and January 2019. Multivariate logistic analysis was used to evaluate MRI-based markers of early recurrence (≤2 years) in the development dataset. Independent factors in the development dataset were investigated using a multivariable Cox analysis. The multivariable logistic and Cox models were verified using the risk score system in the validation dataset. Recurrence-free survival (RFS) was calculated according to MRI-based preoperative markers together with a narrow or wide margin in all datasets.

RESULTS

A narrow resection margin was identified as an independent risk factor for early postoperative recurrence (P < 0.001) according to multivariable Cox analysis. RFS was significantly shorter in patients with narrow resection margins than that of those with wide resection margins (P < 0.005). Patients with the three MRI-based preoperative markers (tumour size > 5 cm, substantial necrosis, and non-smooth margins) combined with a narrow resection margin had a shorter RFS than that of those with a wide margin (P < 0.005). Patients without these markers also benefitted from a wide margin (P < 0.05).

CONCLUSIONS

MRI-based preoperative risk markers in combination with narrow resection margins were associated with a higher recurrence rate compared with wide resection margins, and hence, such patients may benefit from a wide-margin hepatectomy.

摘要

目的

研究基于 MRI 的术前风险标志物在协助临床医生为单发肝细胞癌患者定义适当的手术切缘宽度方面的适用性。

方法

2015 年 1 月至 2019 年 1 月期间,将接受术前 MRI 检查并接受肝切除术的患者随机分为开发(65%)和内部验证(35%)数据集。使用多变量逻辑分析评估开发数据集中基于 MRI 的早期复发(≤2 年)标志物。使用多变量 Cox 分析研究开发数据集中的独立因素。使用验证数据集中的风险评分系统验证多变量逻辑和 Cox 模型。根据所有数据集中基于 MRI 的术前标志物和窄或宽切缘计算无复发生存率(RFS)。

结果

多变量 Cox 分析显示,窄切缘是术后早期复发的独立危险因素(P<0.001)。与宽切缘相比,窄切缘患者的 RFS 明显更短(P<0.005)。与宽切缘相比,具有三个基于 MRI 的术前标志物(肿瘤大小>5cm、实质坏死和不光滑边缘)并伴有窄切缘的患者 RFS 更短(P<0.005)。没有这些标志物的患者也从宽切缘中获益(P<0.05)。

结论

与宽切缘相比,基于 MRI 的术前风险标志物与窄切缘联合使用与更高的复发率相关,因此这些患者可能受益于宽切缘肝切除术。

相似文献

1
MRI-based preoperative markers combined with narrow-margin hepatectomy result in higher early recurrence.基于 MRI 的术前标志物联合窄切缘肝切除术导致更高的早期复发率。
Eur J Radiol. 2022 Dec;157:110521. doi: 10.1016/j.ejrad.2022.110521. Epub 2022 Sep 11.
2
Combined analysis of imaging tumor capsule with imaging tumor size guides the width of resection margin for solitary hepatocellular carcinoma.影像学肿瘤包膜与影像学肿瘤大小联合分析指导单发肝细胞癌的切缘宽度。
Hepatobiliary Pancreat Dis Int. 2022 Dec;21(6):551-558. doi: 10.1016/j.hbpd.2021.12.009. Epub 2021 Dec 29.
3
Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis.R0 肝切除治疗 T1 期肝细胞癌患者手术切缘宽度对复发模式的影响:一项国际多机构分析。
J Gastrointest Surg. 2020 Jul;24(7):1552-1560. doi: 10.1007/s11605-019-04275-0. Epub 2019 Jun 26.
4
Hepatectomy for Solitary Hepatocellular Carcinoma: Resection Margin Width Does Not Predict Survival.肝切除术治疗单发肝细胞癌:切缘宽度不预测生存。
J Gastrointest Surg. 2021 Jul;25(7):1727-1735. doi: 10.1007/s11605-020-04765-6. Epub 2020 Aug 10.
5
Surgical Margin Affects the Long-Term Prognosis of Patients With Hepatocellular Carcinoma Undergoing Radical Hepatectomy Followed by Adjuvant TACE.手术切缘影响根治性肝切除术后辅助 TACE 治疗的肝细胞癌患者的长期预后。
Oncologist. 2023 Aug 3;28(8):e633-e644. doi: 10.1093/oncolo/oyad088.
6
Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.针对孤立性肝细胞癌,宽切缘与窄切缘肝部分切除术的前瞻性随机试验。
Ann Surg. 2007 Jan;245(1):36-43. doi: 10.1097/01.sla.0000231758.07868.71.
7
MRI-based prediction of the need for wide resection margins in patients with single hepatocellular carcinoma.基于磁共振成像(MRI)对单发性肝细胞癌患者手术切缘宽度需求的预测
Eur Radiol. 2025 Apr;35(4):1772-1784. doi: 10.1007/s00330-024-11043-5. Epub 2024 Sep 5.
8
A wide-margin liver resection improves long-term outcomes for patients with HBV-related hepatocellular carcinoma with microvascular invasion.广泛肝切除术可改善伴有微血管侵犯的 HBV 相关肝细胞癌患者的长期预后。
Surgery. 2019 Apr;165(4):721-730. doi: 10.1016/j.surg.2018.09.016. Epub 2018 Dec 13.
9
Anatomic resection and wide resection margin play an important role in hepatectomy for hepatocellular carcinoma with peritumoural micrometastasis.解剖性切除及宽切缘在伴有肿瘤周围微转移的肝细胞癌肝切除术中起着重要作用。
ANZ J Surg. 2019 Nov;89(11):E482-E486. doi: 10.1111/ans.15396. Epub 2019 Oct 16.
10
Impact on Oncological Outcomes and Intent-to-Treat Survival of Resection Margin for Transplantable Hepatocellular Carcinoma in All-Comers and in Patients with Cirrhosis: A Multicenter Study.移植性肝细胞癌全人群和肝硬化患者切缘对肿瘤学结局和意向治疗生存的影响:一项多中心研究。
World J Surg. 2020 Jun;44(6):1966-1974. doi: 10.1007/s00268-020-05424-2.

引用本文的文献

1
The Roles of tRNA-Derived Fragments in Cancer: Updates and Perspectives.tRNA衍生片段在癌症中的作用:最新进展与展望
Int J Mol Sci. 2025 Jun 17;26(12):5822. doi: 10.3390/ijms26125822.
2
Radiotherapy plus a self-gelation powder encapsulating tRF5-GlyGCC inhibitor potentiates natural kill cell immunity to prevent hepatocellular carcinoma recurrence.放射疗法加一种包裹tRF5-GlyGCC抑制剂的自凝胶化粉末可增强自然杀伤细胞免疫,以预防肝细胞癌复发。
J Nanobiotechnology. 2025 Feb 10;23(1):100. doi: 10.1186/s12951-025-03133-3.